Opens in a new tab
Wednesday, 18 November 2026
EVIDENCE. INTERPRETED.
Pharmacally

FDA

Approvals, trial readouts, research and drug safety alerts, interpreted by pharmacists and checked against the primary source.

Advertisement · Remove ads
970 × 90

Latest in FDA

8 stories · every one Fact-Checked
Rain-soaked road with a painted yellow STOP sign for traffic control.Clinical TrialsNewron Hits a Regulatory Speed Bump as FDA Pauses U.S. Enrollment in ENIGMA-TRS 2Newron Pharmaceuticals reported that the U.S. Food and Drug Administration has paused U.S. enrollment in its Phase III ENIGMA-TRS 2 trial of evenamide following a sudden death at…30 Apr 2026 · 2 min read
Fact-Checked
laptops, meeting, businessmen, coworkers, colleagues, business meeting, conference room, meeting room, startup, start-up, notebooks, creative, company, silicon valley, modern, office, conference, table, discussion, business, team, computers, desk, technology, vaio, people, working, meeting, meeting, meeting, meeting, meeting, business meeting, office, office, discussion, discussion, business, business, business, team, teamHealth TidingsLantern Pharma Plans FDA Meeting on HARMONIC Trial Amendments for LP-300 in NSCLCLantern Pharma will seek FDA guidance on proposed HARMONIC trial amendments following preliminary data showing improved progression-free survival with LP-300 in EGFR L858R-mutant NSCLC patients who progressed after…21 Apr 2026 · 3 min read
Fact-Checked
16792957331_a8876db5bd_4kHealth TidingsFDA Shines a Floodlight on Hidden Trial Data, Urges Sponsors to Report Missing ResultsThe FDA urged compliance after finding nearly 30% of applicable trials lacked posted results, highlighting risks of publication bias and signaling potential enforcement actions.14 Apr 2026 · 3 min read
Fact-Checked
40795Medical DevicesUK and US Advance Joint Framework for Medical Device RegulationThe Medicines and Healthcare products Regulatory Agency and U.S. Food and Drug Administration are strengthening cooperation to streamline medical device regulations, aiming to speed up access to innovative…5 Apr 2026 · 3 min read
Fact-Checked
Gemini_Generated_Image_s5dyxts5dyxts5dyHealth TidingsFDA Clears IND for Sialic Acid Prodrug UX016 in GNEMUltragenyx’s UX016 enters clinical testing after FDA IND clearance, targeting sialic acid deficiency in GNE myopathy with a Phase 1/2 study set to begin in 2026.30 Mar 2026 · 3 min read
Fact-Checked
2150071970New Drug ApprovalFDA Grants Accelerated Approval to Rocket’s Kresladi Gene Therapy for Rare Pediatric Disorder LAD-Ihe FDA has approved Kresladi (marnetegragene autotemcel), the first gene therapy for severe LAD-I in children who lack a matched stem cell donor, marking a milestone for rare…27 Mar 2026 · 3 min read
Fact-Checked
14258Medical DevicesNovocure Reports Encouraging Phase 2 Data for TTFields in Pancreatic CancerNovocure reported positive Phase 2 PANOVA-4 results showing TTFields therapy with atezolizumab and gemcitabine/nab-paclitaxel significantly improved disease control rate compared with historical chemotherapy outcomes in metastatic pancreatic cancer.26 Mar 2026 · 3 min read
Fact-Checked
Encoded-Therapeutics-headquarters-in-South-San-Francisco_11zonClinical TrialsEncoded Aligns with FDA on Pivotal ENDEAVOR Trial Design for ETX101 in Dravet SyndromeFDA alignment on the ENDEAVOR pivotal study advances development of Encoded’s ETX101 gene therapy for SCN1A-positive Dravet syndrome, with first clinical data anticipated starting in late 2026.26 Mar 2026 · 2 min read
Fact-Checked
Page 1 of 1